RECALLS AND SAFETY ALERTS MUSCLE INJURY FROM HIGH DOSES OF ZOCOR

June 8, 2010

FDA is informing healthcare professionals that a preliminary review of a large clinical trial shows an increased risk of muscle injury in patients taking the highest dose of the statin drug simvastatin. Simvastatin is sold as Zocor, and is also an i...



Full Story Below

Rapid Response
Free Case Evaluation


The Help You Need,
When You Need it Most

Please Type The Number You See Below

6497

More from FDA News Directory

Claim Your Attorney Profile
Lawyer Central Legal Sites
  Injury     Bankruptcy     Dangerous Products     Family     Real Estate     Estate Planning     Immigration     Disability     Employment     Toxic Torts     Criminal     Litigation  

Find us on Facebook! Follow us on Twitter!

Lawyer State Directories
Alabama | Alaska | Arizona | Arkansas | California | Colorado | Connecticut | Delaware | Florida | Georgia | Hawaii | Idaho | Illinois | Indiana | Iowa | Kansas | Kentucky | Louisiana | Maine | Maryland | Massachusetts | Michigan | Minnesota | Mississippi | Missouri | Montana | Nebraska | Nevada | New Hampshire | New Jersey | New Mexico | New York | North Carolina | North Dakota | Ohio | Oklahoma | Oregon | Pennsylvania | Rhode Island | South Carolina | South Dakota | Tennessee | Texas | Utah | Vermont | Virginia | Washington | West Virginia | Wisconsin | Wyoming |
May 27, 2012
Terms & Conditions
Site Map


Follow @lawyercentral